project id: TCGA-CESC; case submitter id: TCGA-EK-A2RN; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.2; rna integrity number: 5.7; age at index: 45; days to birth: -16487; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1964; age at diagnosis: 16487; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic t: T2b; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 71.0; figo stage: Stage IB1; icd 10 code: C53.9; last known disease status: not reported; morphology: 8071/3; primary diagnosis: Squamous cell carcinoma, keratinizing, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; weight: 20.0; composition: Not Reported; days to collection: 756; initial weight: 60.0; oct embedded: false; preservation method: Unknown; sample id: 24bacabf-8c6f-416a-b1f3-b0baaa2f0ad9; sample submitter id: TCGA-EK-A2RN-01A; portion id: 6f238c3e-60a9-41bd-b516-6ed2bd61abea; portion submitter id: TCGA-EK-A2RN-01A-12; slide id: 64df7972-c0e7-4c0a-ac48-2065773aaf92; slide submitter id: TCGA-EK-A2RN-01A-01-TS1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 95.0; percent tumor nuclei: 98.0; section location: TOP;